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  EVIDENCE-BASED ANSWER 
A combination of laxatives, behavioral therapy, and balanced diet is the treatment of choice for pediatric 
constipation (strength of recommendation [SOR]: B, based on randomized, nonrandomized, controlled and 
uncontrolled clinical trials). Laxatives are used for disimpaction and maintenance therapy. 
Trials that compare different laxatives have shown similar effectiveness, although polyethylene glycol (PEG) 
3350 (MiraLax) may be better tolerated (SOR: B). The roles of dietary changes and acupuncture have been 
minimally studied. 
  EVIDENCE SUMMARY 
Constipation in toddlers is characterized by a delay or difficulty in defecation that is present for 2 or more 
weeks. It is a common problem, accounting for 3% of all general pediatric visits. In most children, constipation 
is functional without pathological cause. Treatment for pathologic constipation is not addressed here. 
Laxative therapies were compared in 2 studies. An unblinded, randomized, crossover trial enrolled 37 children 
referred for subspecialty evaluation of functional constipation. It found that PEG 3350 and lactulose were 
equivalent in improving stool frequency, stool form, and ease of passage. 
However, there was a significant difference in total stool transit time in subjects taking PEG compared with 
those taking lactulose (47.6 hours vs 55.3 hours, respectively; P=.038). In addition, twice as many parents and 
guardians rated PEG effective as those rating lactulose effective (84% vs 46%); and 73% of parents preferred 
PEG to lactulose.1 
A randomized trial compared PEG with milk of magnesia in 49 children with functional constipation and 
encopresis. Follow-up at 1, 3, 6, and 12 months revealed similar effectiveness in increasing bowel movement 
frequency, decreasing soiling episodes, and decreasing abdominal pain. It also revealed that PEG was more 
palatable and better-tolerated than milk of magnesia (33% of children refused to take milk of magnesia, 
whereas none refused PEG). No side effects from PEG were reported.2 
Behavioral modification has been studied for constipation-related encopresis. A randomized controlled trial of 
87 children with fecal soiling compared the effect of enhanced toilet training (including behavioral therapy) with 
aggressive medical management that included disimpaction, enemas, and regular laxative therapy. After 12 
months, the enhanced toilet training with behavioral therapy was more effective in reducing daily frequency of 
soiling (78% of the children had significantly decreased average daily frequency of soiling compared with 41% 
in the aggressive medical management group; P<.0001; absolute risk reduction=0.37; number needed to treat 
for 1 year=2.7).3 
Dietary management centers on a balanced diet with whole grains, fruits, and vegetables. A case-control study 
evaluated 291 subjects with constipation and compared their diet with 1602 controls. Mean daily fiber intake 
was lower in the constipation group. Compared with fiber intake of more than 29 g/d, the relative risk was 8.0 
for fiber intake of less than 12.4 g/d.4 
A nonrandomized, controlled trial of acupuncture treatment enrolled 17 children with history of constipation for 
a minimum of 6 months. Bowel movement frequency improved in both males (1.5 ± 0.1/week to 4.4 ± 
0.6/week; P<.01) and females (1.4 ± 0.3/week to 5.6 ± 1.1/week; P<.01) after 10 acupuncture sessions. No 
other bowel movement parameter was reported.5 
  RECOMMENDATIONS FROM OTHERS 
The North American Society for Pediatric Gastroenterology and Nutrition (NASPGN) recommends parental 
education, initial disimpaction as needed, and maintenance therapy with a balanced diet, behavioral 
modification, and laxatives for all children aged >1 year. Recommended laxatives include mineral oil, 
magnesium hydroxide, lactulose, and sorbitol. Behavior modification includes regular toileting, unhurried time 
on the toilet after meals, diary of stool frequency, and a reward system.6 The American Academy of Pediatrics 
supports the above guidelines. 
A multispecialty panel from the University of Michigan used a structured literature review as a basis for a 
consensus guideline. The resulting protocol was similar to the NASPGN protocol, with the addition of stool 
softeners as an alternative to laxatives.7 
CLINICAL COMMENTARY 
After disimpaction, try bowel training, exercise, 
dietary fiber, and increased fluid 
 
Mark  R.  Ellis,  MD, MSPH 
Cox Health Systems, Springfield, MO 
Successful treatment of chronic constipation in children involves skillful use of diet and 
lifestyle modification, medication, and behavioral interventions, especially if encopresis 
accompanies the constipation. After initial disimpaction with lubricant laxatives, osmotic 
laxatives, and enemas, I recommend a maintenance program of bowel training, exercise, 
dietary fiber, and increased fluid intake. Effective bowel training includes having toilet-
trained children sit on the commode after breakfast and prior to afternoon outdoor play. 
In keeping with Healthy People 2010 recommendations, as well as studies that link diets 
rich in fiber to decreased constipation, I encourage parents of toddlers and children to 
provide them with ample fruits, vegetables, and 6 servings of whole grains per day. I 
address psychosocial aspects of chronic constipation by acknowledging that family 
tensions may surround a child’s bowel habits, assisting parents to establish a sense of 
control within their child, advocating a nonpunitive approach to soiling accidents, and 
suggesting positive reinforcement of their child’s successes. 
For medical management, I use primarily lactulose, although PEG 3350 (Miralax) has also 
been shown effective and safe for long-term use. I avoid mineral oil, due to the rare 
association with lipoid pneumonia; I also avoid sodium phosphate (Fleet) enemas in 
children aged <2 years, due to the associated risks of electrolyte disturbances and cardiac 
arrest in this population. 
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D R U G  B R A N D  N A M E S  
Cetirizine • Zyrtec 
Clemastine • Tavist 
Doxepin, topical • Zonalon 
Fexofenadine • Allegra 
Hydroxyzine • Atarax, Vistarol 
Lansoprazole • Prevacid 
Lidocaine and prilocaine, topical • EMLA cream 
Loratadine • Claritin 
Omeprazole • Prilosec 
Pantoprazole • Protonix 
Pimecrolimus • Elidel 
Polyethylene glycol 3350 • MiraLax 
Rabeprazole • AcipHex 
Tacrolimus • Prograf 
 
